Moderna Aktie
WKN DE: A2N9D9 / ISIN: US60770K1079
06.03.2021 18:50:49
|
Moderna To Supply 13 Mln Doses Of COVID-19 Vaccine To The Philippines
(RTTNews) - Moderna, Inc. (MRNA) announced that it has supply agreement with the Government of The Philippines for 13 million doses of the COVID-19 Vaccine Moderna.
As per the terms of deal, deliveries would begin in mid-2021.
The COVID-19 Vaccine Moderna is not currently approved for use in the Philippines. But the Company will work with regulators to pursue necessary approvals prior to distribution, the company said in a statement.
The company also stated that the separate agreement with the Philippine Government and private sector for the supply of an additional 7 million doses is also anticipated.
"We thank the Government and the private sector for their collaboration to bring the COVID-19 Vaccine Moderna to the Philippines," said Stphane Bancel, Chief Executive Officer of Moderna.
"We appreciate the confidence in Moderna, and our mRNA platform demonstrated by the Government of the Philippines. We remain committed to making our vaccine available on every continent to help end this global pandemic."

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Moderna Incmehr Nachrichten
01.04.25 |
Starker Wochentag in New York: S&P 500 beendet den Handel im Plus (finanzen.at) | |
31.03.25 |
Handel in New York: S&P 500 verbucht zum Ende des Montagshandels Gewinne (finanzen.at) | |
31.03.25 |
S&P 500-Handel aktuell: Das macht der S&P 500 nachmittags (finanzen.at) | |
31.03.25 |
Börse New York in Rot: So performt der S&P 500 am Montagmittag (finanzen.at) | |
31.03.25 |
Anleger in New York halten sich zurück: S&P 500 zum Handelsstart mit Abgaben (finanzen.at) | |
27.03.25 |
S&P 500-Papier Moderna-Aktie: So viel Gewinn hätte eine Investition in Moderna von vor 5 Jahren abgeworfen (finanzen.at) | |
26.03.25 |
Handel in New York: S&P 500 zum Ende des Mittwochshandels im Minus (finanzen.at) | |
26.03.25 |
Verluste in New York: S&P 500 präsentiert sich nachmittags schwächer (finanzen.at) |
Analysen zu Moderna Incmehr Analysen
19.11.24 | Moderna Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.09.24 | Moderna Underweight | JP Morgan Chase & Co. | |
05.08.24 | Moderna Sector Perform | RBC Capital Markets | |
12.01.24 | Moderna Outperform | RBC Capital Markets | |
03.11.23 | Moderna Buy | Goldman Sachs Group Inc. |
Aktien in diesem Artikel
Moderna Inc | 23,41 | -8,43% |
|